Charles Schwab has expanded its cryptocurrency trading service to include Solana (SOL), Avalanche (AVAX), and Chainlink (LINK), joining Bitcoin and Ethereum on its platform. This allows eligible US retail investors to trade five cryptocurrencies directly through Schwab's website, mobile app, and thinkorswim platform with a 0.75% transaction fee. The move responds to customer demand for more digital asset options and integrates crypto trading with traditional investments without needing separate accounts. Schwab plans to add more cryptocurrencies over time but currently excludes residents of New York, Louisiana, and international clients.
Charles Schwab's expansion of cryptocurrency trading to include Solana, Avalanche, and Chainlink offers context for crypto market activity. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Nov 09, 2026 21:02 WIB: out of 50 priced major cryptocurrencies, 19 rose and 29 fell. Notable movers include ENJ (Enjin Coin) at Rp439 with a 6.11% increase and 100% buy order activity, XRP (Ripple) at Rp19,723 with a 5.99% decrease and 62% buy order activity, and ETH (Ethereum) at Rp38,308,227 with a 5.23% decrease and 64% buy order activity.
Neo Security, Inc. has launched Neoverse, a free AI software intelligence engine that researches and classifies over 4 million AI apps, extensions, and servers to assess their capabilities and security risks. Integrated into Neo's platform, Neoverse ...
AnorTech Inc. completed a $7.55 million share exchange with Nasdaq-listed Greenland Mines, increasing Greenland Mines' ownership in AnorTech to 19.9%. Greenland Mines acquired over 25 million AnorTech shares in exchange for Greenland Mines shares val...
Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
